Just to give a perspective on this Hervaxx results and the significance of it.
As those of us who have been on this journey, we all know that every drug have a fixed patent life. After which, biosims will be able to come to market to compete against the original. Consider this. If biosims think it worthwhile to try and just get a small piece of the market from the original, what do you think it will be worth for a drug that can totally take over the whole market of another by being better, safer and cheaper?
And here, we are talking about Herceptin's multi-billion dollars market. And here, we are talking about just ONE drug candidate out of a potential myriads of drug candidates that IMU will have.
The above is how I see IMU now. It is going to be big. Really big. All in my very excited opinion only
Ann: Investor Webinar - Final HER-Vaxx Overall Survival Results, page-9
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |